Milestone Pharmaceuticals (MIST) PT Raised to $2 at Jefferies
Tweet Send to a Friend
Jefferies analyst Dennis Ding raised the price target on Milestone Pharmaceuticals (NASDAQ: MIST) to $2.00 (from $1.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
